Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Alpa Laboratories Limited

Market Cap 98Cr 1.03Cr 90.39L 83.61L 78.04L 1.46Cr 1.48Cr 9.94Cr 3.87Cr 48Cr 3.88Cr 3.8Cr 166.97Cr P/E 2024
10.4x
P/E 2025 11.2x
Enterprise Value -15Cr -15.8L -13.81L -12.77L -11.92L -22.38L -22.54L -1.52Cr -59.04L -7.34Cr -59.32L -58.03L -26Cr EV / Sales 2024
0.81x
EV / Sales 2025 0.94x
Free-Float
42.71%
Yield 2024 *
-
Yield 2025 -
29/05 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
11/04 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
25/02 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
12/02 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
13/25/13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
01/25/01 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
28/25/28 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/25/14 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
13/25/13 Alpa Laboratories Limited Appoints Srashti Chopra as Company Secretary and Compliance Officer CI
13/25/13 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2024 CI
14/24/14 Alpa Laboratories Limited Announces Resignation of Swati Bagh as Company Secretary and Compliance Officer, Effective December 10, 2024 CI
31/24/31 Alpa Laboratories Limited Appoints Pratik Shah as an Additional Director CI
13/24/13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
1 day-0.78%
1 week-3.81%
Current month-5.38%
1 month-2.28%
3 months+12.32%
6 months-12.79%
Current year-13.01%
1 week 66.9
Extreme 66.9
72.4
1 month 66.9
Extreme 66.9
74.8
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
108.3
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 28/05/2016
Director of Finance/CFO 65 -
Compliance Officer - 11/04/2026
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 01/01/1967
Director/Board Member - 28/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-3.81%-30.47%+1.93% 1.52Cr
+1.34%+3.15%+11.88%+88.11% 4.67TCr
+1.65%+4.10%+55.40%+97.46% 3.43TCr
+4.73%+2.49%-5.60%+41.81% 1.16TCr
+1.37%-0.24%+13.42%+96.33% 1.14TCr
-0.57%-0.57%+37.43%+124.36% 908.73Cr
+1.11%-2.15%+14.48%+41.36% 697.6Cr
-0.98%+1.64%+33.92%+249.20% 662.03Cr
-0.32%+3.50%+51.82%-14.30% 655.32Cr
+1.32%-1.72%-34.40%-0.52% 500.36Cr
Average +0.89%-0.22%+14.79%+72.57% 1.38TCr
Weighted average by Cap. +1.38%+0.94%+24.42%+86.90%

Financials

2024 2025
Net sales 108.74Cr 1.15Cr 1.01Cr 93L 86.81L 1.63Cr 1.64Cr 11Cr 4.3Cr 53Cr 4.32Cr 4.23Cr 185.73Cr 112.45Cr 1.19Cr 1.04Cr 96.18L 89.77L 1.69Cr 1.7Cr 11Cr 4.45Cr 55Cr 4.47Cr 4.37Cr 192.07Cr
Net income 17Cr 17.75L 15.51L 14.35L 13.39L 25.14L 25.33L 1.71Cr 66.34L 8.25Cr 66.65L 65.21L 29Cr 20Cr 20.64L 18.03L 16.68L 15.57L 29.23L 29.44L 1.98Cr 77.13L 9.59Cr 77.49L 75.81L 33Cr
Net Debt -88Cr -92.7L -81.01L -74.93L -69.94L -1.31Cr -1.32Cr -8.9Cr -3.46Cr -43Cr -3.48Cr -3.41Cr -149.63Cr -112.69Cr -1.19Cr -1.04Cr -96.38L -89.96L -1.69Cr -1.7Cr -11Cr -4.46Cr -55Cr -4.48Cr -4.38Cr -192.47Cr
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
453
Date Price Change Volume
22/26/22 67.58 -0.78% 12,878
19/26/19 68.11 +0.37% 20,235
18/26/18 67.86 -2.56% 37,508
17/26/17 69.64 -1.29% 14,275
16/26/16 70.55 +0.41% 21,794
  1. Stock Market
  2. Stocks
  3. ALPA Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!